Novateor Resear.

  • Market Cap: Micro Cap
  • Industry: FMCG
  • ISIN: INE08JY01013
  • NSEID:
  • BSEID: 542771
INR
32.00
0.00 (0.00%)
BSENSE

Sep 02, 03:30 PM

BSE+NSE Vol: 3000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

3.0 k (400.00%) Volume

Shareholding (Mar 2026)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

50.75%

Why is Novateor Research Laboratories Ltd falling/rising?

02-Sep-2026

As of 01-Sep, Novateor Research Laboratories Ltd's stock price is at 32.00, showing no change and underperforming its sector by 2.51%. The stock has exhibited erratic trading patterns and low liquidity, contributing to its stagnation and potential decline.

As of 01-Sep, Novateor Research Laboratories Ltd's stock price is currently at 32.00, with no change noted (0.00%). The stock has underperformed its sector by 2.51% today, indicating a decline in performance relative to its peers. Over the past week, the stock has decreased by 2.59%, which is more significant than the Sensex's decline of 0.92% during the same period. <BR><BR>In terms of trading activity, the stock has shown erratic trading patterns, having not traded on 5 out of the last 20 days. This inconsistency may contribute to investor uncertainty. Although the stock is trading above its 20-day and 200-day moving averages, it is below its 5-day, 50-day, and 100-day moving averages, suggesting a short-term downward trend. <BR><BR>Additionally, while there has been a rise in investor participation, with delivery volume increasing by 0% against the 5-day average, the overall liquidity remains low, with only 2% of the 5-day average traded value. This low liquidity can further exacerbate price movements and contribute to the stock's current performance. <BR><BR>Overall, the combination of underperformance against the sector, erratic trading, and low liquidity are contributing factors to the stock's current stagnation and potential decline.

View full answer

Which are the latest news on Novateor Resear.?

02-Sep-2026
No latest news for Novateor Resear. found.

Who are in the management team of Novateor Resear.?

01-Sep-2026

The management team of Novateor Resear includes Navdeep Subhashbhai Mehta (Managing Director & CFO), Tejal Navdeep Mehta (Whole-time Director), and several Independent Directors: Anand Rajendra Shah, Chintan Pankaj Shah, and Sindhav Vipulbhai, along with Non-Executive Director Jitin Jaysukh Doshi.

The management team of Novateor Resear includes the following individuals:<BR><BR>1. **Navdeep Subhashbhai Mehta** - Managing Director & CFO<BR>2. **Tejal Navdeep Mehta** - Whole-time Director<BR>3. **Anand Rajendra Shah** - Independent Director<BR>4. **Chintan Pankaj Shah** - Independent Director<BR>5. **Sindhav Vipulbhai** - Independent Director<BR>6. **Jitin Jaysukh Doshi** - Non Executive Director<BR><BR>If you need more specific information about their roles or responsibilities, feel free to ask!

View full answer

What does Novateor Resear. do?

01-Sep-2026

Novateor Research Laboratories Ltd is a micro-cap company in the FMCG industry, incorporated in 2011 and converted to a public company in 2019. As of March 2020, it reported net sales and profit of 0 Cr, with a market cap of INR 20 Cr.

Overview: <BR>Novateor Research Laboratories Ltd operates in the FMCG industry and is classified as a micro-cap company.<BR><BR>History: <BR>The company was originally incorporated as Novateor Research Laboratories Private Limited in 2011 and was converted into a Public Limited Company with its name changed to Novateor Research Laboratories Limited on April 22, 2019. The latest quarterly results reported net sales and net profit of 0 Cr for March 2020.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 0 Cr (Quarterly Results - Mar 2020) <BR>Most recent Net Profit: 0 Cr (Quarterly Results - Mar 2020) <BR>Market-cap value: INR 20 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 194.00 <BR>Industry P/E: 67 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.08 <BR>Return on Equity: 1.00% <BR>Price to Book: 2.49 <BR><BR>Contact Details: <BR>Details: No Company Details Available <BR>Registrar Address: Not available.

View full answer

Who are the peers of the Novateor Resear.?

01-Sep-2026

Novateor Resear.'s peers include KMG Milk Food, Lake Shore, Abram Food, Sonalis Consumer, Paramount Cosmet, Indong Tea Co, Shivamshree Busi, Tapi Fruit, and Walpar Nutrition. In terms of management risk, growth, and capital structure, Sonalis Consumer and Walpar Nutrition perform best, while Novateor Resear. shows below-average management risk and capital structure.

Peers: The peers of Novateor Resear. are KMG Milk Food, Lake Shore, Abram Food, Sonalis Consumer, Paramount Cosmet, Indong Tea Co, Shivamshree Busi, Tapi Fruit, and Walpar Nutrition.<BR><BR>Quality Snapshot: Excellent management risk is observed at Sonalis Consumer and Walpar Nutrition, while Average management risk is found at Abram Food, and Below Average management risk is noted at Novateor Resear., Paramount Cosmet, Indong Tea Co, Shivamshree Busi, Tapi Fruit, and the rest. Growth is Excellent at Sonalis Consumer, Good at Abram Food and Walpar Nutrition, Average at Novateor Resear., and Below Average at KMG Milk Food, Lake Shore, Paramount Cosmet, Indong Tea Co, Shivamshree Busi, and Tapi Fruit. Capital Structure is Good at Sonalis Consumer and Walpar Nutrition, Average at Abram Food and Shivamshree Busi, and Below Average at Novateor Resear., KMG Milk Food, Lake Shore, Paramount Cosmet, Indong Tea Co, and Tapi Fruit.<BR><BR>Return Snapshot: The peer with the highest 1-year return is KMG Milk Food at N/A, while the peer with the lowest 1-year return is Abram Food at -61.61%. Novateor Resear. has a 1-year return of -4.16%, which is better than Abram Food but worse than KMG Milk Food. Additionally, peers such as Lake Shore, Abram Food, Sonalis Consumer, Indong Tea Co, and Tapi Fruit have negative six-month returns.

View full answer

How big is Novateor Resear.?

01-Sep-2026

As of 31st August, Novateor Research Laboratories Ltd has a market capitalization of 20.00 Cr, with recent net sales of 0.13 Cr and a net profit loss of 0.02 Cr. Shareholder's funds are 10.54 Cr, and total assets amount to 12.61 Cr as of March 2025.

As of 31st August, Novateor Research Laboratories Ltd has a market capitalization of 20.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest quarter ending March 2020, the company reported Net Sales of 0.13 Cr and a Net Profit loss of 0.02 Cr.<BR><BR>The latest annual period for the balance sheet is March 2025, with Shareholder's Funds amounting to 10.54 Cr and Total Assets of 12.61 Cr.

View full answer

When is the next results date for Novateor Research Laboratories Ltd?

27-May-2026

Novateor Research Laboratories Ltd will announce its results on 30 May 2026.

Novateor Research Laboratories Ltd is scheduled to declare its results on 30 May 2026.

View full answer

Who are the top shareholders of the Novateor Resear.?

17-Jul-2025

The top shareholders of Novateor Resear include Navdeep Subhashbhai Mehta with 29.56%, individual investors with 26.45%, and public shareholder Jitin Jaysukhlal Doshi at 3.85%. There are currently no mutual funds or foreign institutional investors holding shares in the company.

The top shareholders of Novateor Resear include the promoters, with Navdeep Subhashbhai Mehta holding the largest stake at 29.56%. Individual investors collectively own 26.45% of the company. The highest public shareholder is Jitin Jaysukhlal Doshi, who holds 3.85%. Notably, there are no mutual funds or foreign institutional investors currently holding shares in the company.

View full answer

Is Novateor Resear. overvalued or undervalued?

09-Jun-2025

As of May 19, 2025, Novateor Research is rated as risky and overvalued, with a PE Ratio of 27.80, negative ROCE of -4.59%, and ROE of 0.38%, despite outperforming the Sensex with an 18.9% return over the past year.

As of 19 May 2025, the valuation grade for Novateor Research has moved from does not qualify to risky, indicating a significant shift in its perceived investment quality. The company is currently deemed overvalued. Key ratios include a PE Ratio of 27.80, a Price to Book Value of 3.51, and an EV to Sales ratio of 23.81, which suggest that the stock is priced high relative to its earnings and book value.<BR><BR>In comparison to its peers, Novateor Research's PE Ratio stands in stark contrast to Max Healthcare Institute Ltd., which has a PE of 100.29, and Apollo Hospitals Enterprise Ltd., with a PE of 69.03, both categorized as very expensive. This highlights the relative valuation concerns for Novateor Research, especially given its negative ROCE of -4.59% and ROE of 0.38%. While Novateor has outperformed the Sensex over the past year with a return of 18.9% compared to the Sensex's 7.55%, the underlying financial metrics suggest caution for potential investors.

View full answer

What is the technical trend for Novateor Resear.?

09-Jun-2025

As of May 15, 2025, Novateor Research's technical trend is neutral, with no clear bullish or bearish indicators, as the stock price remains unchanged at 57.50 despite strong long-term performance relative to the Sensex.

As of 15 May 2025, the technical trend for Novateor Resear has changed from mildly bearish to does not qualify. Given the lack of specific technical indicators such as MACD, RSI, or moving averages, and the current price remaining unchanged at 57.50, there is insufficient data to form a definitive bullish or bearish stance. The stock's performance relative to the Sensex shows strong returns over the longer term, but current technical analysis does not provide a clear direction.

View full answer

Has Novateor Resear. declared dividend?

30-Apr-2025

No Dividend History Available

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

FMCG

stock-summary
Market cap

INR 20 Cr (Micro Cap)

stock-summary
P/E

194.00

stock-summary
Industry P/E

81

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.08

stock-summary
Return on Equity

1.00%

stock-summary
Price to Book

2.49

Revenue and Profits:
Net Sales:
0 Cr
(Quarterly Results - Mar 2020)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0%
0%
0.0%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
433.33%
0%
433.33%

Novateor Resear. for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Board Meeting Intimation for Approval Of Agenda Related To Ensuing AGM And Other Businesses With The Permission Of Chairman

31-Aug-2026 | Source : BSE

Novateor Research Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/09/2026 inter alia to consider and approve the agenda related to ensuing Annual General Meeting and other businesses with the permission of Chairman.

The Company Has Entered Into Marketer And Manufacturing Agreement With Smart Laboratories Private Limited

20-Aug-2026 | Source : BSE

The company has entered into Marketer and Manufacturing Agreement with Smart Laboratories Private Limited and received Purchase order from them for 10000 units Advance Teeth Whitening Serum worth Rs. 840000 excluding GST.

Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018

15-Aug-2026 | Source : BSE

Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation 2018 for the quarter ended June 30 2026

Corporate Actions stock-summary

stock-summary
BOARD MEETING

(03 Sep 2026)

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
35.90%
EBIT Growth (5y)
2.47%
EBIT to Interest (avg)
-0.34
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.05
Sales to Capital Employed (avg)
0.22
Tax Ratio
9.09%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-2.92%
ROE (avg)
1.10%

Valuation key factors

Factor
Value
P/E Ratio
194
Industry P/E
81
Price to Book Value
1.68
EV to EBIT
-19.92
EV to EBITDA
-19.92
EV to Capital Employed
1.65
EV to Sales
5.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.41%
ROE (Latest)
0.87%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Navdeep Subhashbhai Mehta (24.8%)

Highest Public shareholder

Jitin Jaysukhlal Doshi (8.03%)

Individual Investors Holdings

30.0%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'20 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'20",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.13",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.02",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-153.85%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2025 is 24.75% vs 150.63% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2025 is -140.00% vs 66.67% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.47",
          "val2": "1.98",
          "chgp": "24.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.12",
          "val2": "-0.03",
          "chgp": "-300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.05",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.02",
          "val2": "0.05",
          "chgp": "-140.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4.86%",
          "val2": "-1.52%",
          "chgp": "-3.34%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Mar'20",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Mar 2020 is 182.61% vs 87.76% in Mar 2020",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Mar 2020 is -500.00% vs 200.00% in Mar 2020",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'20",
        "Mar'20",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.60",
          "val2": "0.92",
          "chgp": "182.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.32",
          "val2": "-0.31",
          "chgp": "-3.23%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.05",
          "val2": "0.02",
          "chgp": "150.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.04",
          "val2": "0.01",
          "chgp": "-500.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-12.31%",
          "val2": "-33.70%",
          "chgp": "21.39%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 129.75% vs -3.97% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 166.67% vs -25.00% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2.78",
          "val2": "1.21",
          "chgp": "129.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.13",
          "val2": "-0.33",
          "chgp": "60.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.07",
          "val2": "0.03",
          "chgp": "133.33%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "0.08",
          "val2": "0.03",
          "chgp": "166.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-4.68%",
          "val2": "-27.27%",
          "chgp": "22.59%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'20 - QoQstock-summary

Mar'20
Change(%)
Net Sales
0.13
NA
NA
Operating Profit (PBDIT) excl Other Income
-0.20
NA
NA
Interest
0.00
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
-0.02
NA
NA
Operating Profit Margin (Excl OI)
-153.85%
NA%
NA
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

Half Yearly Results Snapshot (Standalone) - Sep'25stock-summary

Sep'25
Mar'25
Change(%)
Net Sales
2.47
1.98
24.75%
Operating Profit (PBDIT) excl Other Income
-0.12
-0.03
-300.00%
Interest
0.05
0.05
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.02
0.05
-140.00%
Operating Profit Margin (Excl OI)
-4.86%
-1.52%
-3.34%
Values in Rs Cr.
Direction Arrows
Net Sales

Growth in half year ended Sep 2025 is 24.75% vs 150.63% in Mar 2025

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2025 is -140.00% vs 66.67% in Mar 2025

Nine Monthly Results Snapshot (Standalone) - Mar'20stock-summary

Mar'20
Mar'20
Change(%)
Net Sales
2.60
0.92
182.61%
Operating Profit (PBDIT) excl Other Income
-0.32
-0.31
-3.23%
Interest
0.05
0.02
150.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.04
0.01
-500.00%
Operating Profit Margin (Excl OI)
-12.31%
-33.70%
21.39%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in nine months ended Mar 2020 is 182.61% vs 87.76% in Mar 2020

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Mar 2020 is -500.00% vs 200.00% in Mar 2020

Annual Results Snapshot (Standalone) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
2.78
1.21
129.75%
Operating Profit (PBDIT) excl Other Income
-0.13
-0.33
60.61%
Interest
0.07
0.03
133.33%
Exceptional Items
0.00
0.00
Standalone Net Profit
0.08
0.03
166.67%
Operating Profit Margin (Excl OI)
-4.68%
-27.27%
22.59%
Values in Rs Cr.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 129.75% vs -3.97% in Mar 2024

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2025 is 166.67% vs -25.00% in Mar 2024

stock-summaryCompany CV
About Novateor Research Laboratories Ltd stock-summary
stock-summary
Novateor Research Laboratories Ltd
Micro Cap
FMCG
Novateor Research Laboratories Limited was originally incorporated as Novateor Research Laboratories Private Limited on April 01, 2011 by the Registrar of Companies, Gujarat. Subsequently, the Company was converted into Public Limited Company and name was changed to "Novateor Research Laboratories Limited" dated April 22, 2019.
Company Coordinates stock-summary
Icon
No Company Details Available